China Pharma (CPHI)
Manufactures prescription pharmaceuticals for Chinese distributors across infection, CNS, cardiovascular, respiratory and digestive care.
$0.8410
Pre-market−0.00 (−0.47%)
At close$0.8450(−4.55%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Cost of revenue | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Gross profit | 0 | 0 | −1 | −1 | 0 | 0 | 0 | 0 | 0 | −1 | 0 |
| 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |
| Net income from continuing operations | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |
| Net income | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |
| EPS, basic | −$0.26 | −$0.20 | −$0.30 | −$0.23 | −$0.26 | −$0.18 | −$0.16 | −$0.17 | −$0.23 | −$0.27 | −$0.34 |
| EPS, diluted | −$0.26 | −$0.20 | −$0.30 | −$0.23 | −$0.26 | −$0.18 | −$0.16 | −$0.17 | −$0.23 | −$0.27 | −$0.34 |
| Weighted average shares, basic | 5 | 5 | 5 | 5 | 5 | 4 | 3 | 4 | 4 | 4 | 4 |
| Weighted average shares, diluted | 5 | 5 | 5 | 5 | 5 | 4 | 3 | 4 | 4 | 4 | 4 |
| EBITDA | 0 | 0 | −1 | 0 | −1 | 0 | 0 | 0 | −1 | 0 | 0 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| EBIT | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |